A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH)

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
The purpose of this research is to evaluate the efficacy and the safety of two doses of ZSP1601 for 48 weeks versus placebo in adult NASH patients.
Epistemonikos ID: 2b9ca2d42f55a7424c8be3777058cf3b40e08757
First added on: Feb 19, 2024